ClinicalTrials.Veeva

Menu

CBD-Microglia PET Study

Yale University logo

Yale University

Status and phase

Enrolling
Early Phase 1

Conditions

Healthy
CBD

Treatments

Drug: Intradermal Capsaicin
Drug: Low-dose lipopolysaccharide
Radiation: [11C]PBR28

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04398719
2000026320

Details and patient eligibility

About

This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.

Full description

This study aims to examine the effect of cannabidiol (CBD), pre-treatment, as Epidiolex, on brain microglial activation in healthy human subjects using [11C]PBR28 PET imaging. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects. Lastly, this research study will also examine the relationship between brain microglial activation and central pain sensitization with CBD pre-treatment.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Men and women aged 18- 55 years
  2. No significant medical or neurological illness
  3. No implanted metal devices that may pose a risk during MRI scanning
  4. Within the annual permissible radiation exposure
  5. Able to provide written informed consent.

Exclusion criteria

  1. Current use of any medications
  2. Presence of metal in the body
  3. Pregnancy or lactation

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

15 participants in 2 patient groups, including a placebo group

CBD
Active Comparator group
Treatment:
Radiation: [11C]PBR28
Drug: Low-dose lipopolysaccharide
Drug: Intradermal Capsaicin
Placebo
Placebo Comparator group
Treatment:
Radiation: [11C]PBR28
Drug: Low-dose lipopolysaccharide
Drug: Intradermal Capsaicin

Trial contacts and locations

1

Loading...

Central trial contact

Carly Hewes; Mohini Ranganathan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems